retatrutide nonalcoholic fatty liver disease nash trial Recent guidelines for Non-Alcoholic (NAFLD)/ Fatty Liver Disease (FLD): Are they already outdated and in need of supplementation? Researchers are reporting promising results – FDA Approves First NASH Drug

Also read: Science-Based Hydration Strategies for Better Living & Performance You Didnt Know (05/05/25) Longevity community couldnt resist GLP1s Given our newsletters core focus is on longevity itself, we couldnt help but give the perspective of the longevity community on GLP-1s and other WLMs

Together, we can make sustainable weight loss attainable and tailored to your individual needs

The research is here, but insurance coverage hasnt caught up

But the availability of GLP-1 injectables is rapidly changing, too

The surge of interest largely comes from popular GLP-1 drugs used for diabetes and GLP-1 weight loss treatments

Reconstituted injectable GHK-Cu: 2-8C (refrigerated): 28-30 days stable 15-25C (room temp): Degrades in 3-7 days 30C (warm): Degrades in 24-48 hours Topical serum (opened): 2-8C (refrigerated): 6-12 months 15-25C (room temp): 3-6 months 30C (warm environment): 1-3 months Raw powder (sealed): 2-8C (refrigerated): 24-36 months 15-25C (room temp): 12-24 months 30C (warm): 6-12 months Key takeaway: Every 10C increase in temperature roughly doubles the degradation rate